选择语言

Rhesus macaque Fc gamma RIII / CD16 Protein, His Tag (SPR & BLI & MALS verified)

用户评价
货号-规格
价格
Qty.
FC6-R52H6-50ug
¥2310.00
FC6-R52H6-1mg
¥20790.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    FCGR3

  • 表达区间及表达系统(Source)

    Rhesus macaque CD16, His Tag (FC6-R52H6) is expressed from human 293 cells (HEK293). It contains AA Glu 21 - Gly 206 (Accession # A3RFZ7-1).

    Predicted N-terminus: Glu 21

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    Fc gamma RIII / CD16 Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 23.1 kDa. The protein migrates as 35-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 偶联(Conjugate)

    Unconjugated

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method.

  • 纯度(Purity)

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • 电泳(SDS-PAGE)

    Fc gamma RIII / CD16 SDS-PAGE

    Rhesus macaque CD16, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    Fc gamma RIII / CD16 SEC-MALS

    The purity of Rhesus macaque CD16, His Tag (Cat. No. FC6-R52H6) is more than 90% and the molecular weight of this protein is around 40-50 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-SPR

     Fc gamma RIII / CD16 SPR

    Rhesus macaque CD16, His Tag (Cat. No. FC6-R52H6) captured on CM5 Chip via anti-His antibody can bind Rituximab with an affinity constant of 0.232 μM as determined in SPR assay (Biacore T200) (QC tested).

    Protocol
  • 活性(Bioactivity)-BLI

     Fc gamma RIII / CD16 BLI

    Loaded Rhesus macaque CD16, His Tag (Cat. No. FC6-R52H6) on HIS1K Biosensor, can bind Rituximab with an affinity constant of 0.28 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

CD16 is a low affinity Fc receptor, and has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b). These receptors bind to the Fc portion of IgG antibodies. CD16 encoded by two different highly homologous genes in a cell type-specific manner.CD16 is found on the surface of natural killer cells, neutrophil polymorphonuclear leukocytes, monocytes and macrophages.
CD16a antigen is also known as Low affinity immunoglobulin gamma Fc region receptor III-A, Fc-gamma RIII-alpha. CD16b is a low-affinity, GPI-linked receptor expressed by neutrophils and eosinophils, whereas CD16a is an intermediate affinity polypeptide-anchored transmembrane glycoprotein expressed natural killer cells, macrophages, subpopulation of T-cells, immature thymocytes and placentaltrophoblasts.CD16a is involved in phagocytosis, secretion of enzymes and inflammatory mediators, antibody­dependent cytotoxicity and clearance of immune complexes. Aberrant expression or mutations of CD16a is implicated in susceptibility to recurrent viral infections, systemic lupus erythematosus, and alloimmune neonatal neutropenia.

前沿进展

 
药物研发进展
  • 英文全称:

    Low affinity immunoglobulin gamma Fc region receptor III-A

  • 中文全称:

    低亲和力免疫球蛋白γFc段受体III-A

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    14 详情

  • 最高研发阶段:

    临床二期

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价
  • 背景介绍